Quarterly results, guidance, estimates
50 stories
In the last 7 days, Earnings tracked 14 stories — 14% positive, 7% negative, 79% neutral sentiment, averaging 5.4/10 impact.
Stories appear on this page because our classification stage assigned them this category as their primary topic — each story receives exactly one category per niche, chosen from a fixed list, so a story that touches both a funding round and a product launch in the same week sorts into whichever category best matches its dominant subject, not both. This keeps each category page focused on one beat rather than a blend of unrelated developments, and applies the same source-verification standard used across every story on this site. Sentiment measures the directional read of each development for this category specifically, not the tone of the reporting, and impact weights how consequential a development is — regulatory, financial, or operational — rather than how widely it was syndicated across outlets.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
The Q4 2025 earnings reports from leaders in infrastructure, healthcare, and logistics reveal a resilient corporate landscape despite persistent macro-economic headwinds. Companies like Astec and Alcon are leveraging operational efficiencies and non-discretionary demand to drive margin expansion and long-term growth.
US stock indices climbed on Tuesday as investors positioned themselves ahead of Nvidia’s critical fourth-quarter earnings report. The chipmaker's results are expected to serve as a definitive health check for the global artificial intelligence boom and the sustainability of massive infrastructure spending.
Source: mainlinemedianews.com · advocate-news.com
As the Q4 2025 earnings season intensifies, four key players in the specialized medical technology and biotechnology sectors—Delcath Systems, Butterfly Network, Heron Therapeutics, and Lantheus Holdings—are preparing to report results. Investors are focusing on commercial execution, product adoption rates, and the sustainability of high-growth specialized therapies.
hipages Group and Revolve Group reported financial results that highlight a strategic shift toward recurring revenue models and AI-driven operational efficiency. While hipages is transforming into a SaaS-led ecosystem for Australian trades, Revolve is leveraging data and inventory discipline to navigate a volatile global fashion market.
Source: tickerreport.com · tickerreport.com
Chatham Lodging Trust and Acadia Healthcare both outperformed analyst expectations in their fourth-quarter reports, signaling robust demand in premium lodging and behavioral health services. Both companies introduced optimistic 2026 guidance, reflecting a positive outlook for operational growth and margin expansion.
LifeStance Health Group and Dole have released their fourth-quarter results, providing a roadmap for 2026 that highlights divergent paths in the healthcare and consumer staples sectors. While LifeStance focuses on scaling its mental health platform, Dole navigates a complex global supply chain to maintain its fresh produce leadership.
Bureau Veritas has reported a sector-leading organic revenue growth of 6.5% for the full year 2025, underscoring its resilience and strategic positioning within the Testing, Inspection, and Certification (TIC) market. This performance highlights the company's ability to capitalize on global trends in sustainability and regulatory compliance.
Source: finanznachrichten.de · iberonews.com
Workforce housing leader Civeo and financial services firm Nelnet are scheduled to release quarterly results this Thursday, offering key insights into global commodity infrastructure and the evolving student loan landscape. Investors are watching for margin stability in Civeo's Australian operations and Nelnet's diversification into telecommunications.
Source: dailypolitical.com · dailypolitical.com
Shoals Technologies Group issued a corrected Q4 2025 earnings release to clarify language regarding customer order patterns and strategic intentions. The correction highlights the ongoing volatility in the solar infrastructure sector as project timelines and inventory management remain sensitive to macroeconomic pressures.
Source: itnewsonline.com · manilatimes.net
Hormel Foods and Celsius Holdings are set to report Q4 results, highlighting a sharp divergence between legacy protein producers and high-growth functional beverages. Investors are closely monitoring Hormel's margin recovery and Celsius's inventory stabilization following recent distribution shifts with PepsiCo.
Rocket Companies and Sweetgreen are set to report Q4 earnings, offering critical insights into the health of the US housing market and premium consumer spending. Investors are closely watching Rocket's margin performance amid rate volatility and Sweetgreen's progress with its 'Infinite Kitchen' automation rollout.
Papa John’s and Dell Technologies are set to report Q4 results, offering a dual perspective on consumer discretionary spending and the durability of the AI infrastructure boom. While Papa John’s navigates a competitive pizza landscape, Dell’s performance will be a critical indicator of enterprise tech investment and the PC market recovery.
Investors are bracing for a pivotal set of Q4 earnings reports from Assured Guaranty, Brink’s, and Autodesk, each representing critical barometers for their respective sectors. These reports will provide essential clarity on municipal bond insurance demand, global cash logistics resilience, and the health of the enterprise software market amid shifting macroeconomic conditions.
Source: markets.financialcontent.com · markets.financialcontent.com
A diverse group of mid-cap leaders across home services, healthcare, and fintech are preparing to release their quarterly results. Investors are focused on subscriber retention at Frontdoor and the continued clinical adoption of diagnostics at Natera and Lantheus.
A diverse group of mid-to-large cap companies across consumer staples, healthcare, and tech are set to report Q4 results tomorrow. Investors are looking for signs of margin expansion amid stabilizing inflation and the impact of generative AI on software demand.
A cross-section of the global economy—spanning energy drinks, cloud storage, and sports betting—is set to report quarterly results on February 26, 2026. Investors are looking for signs of consumer resilience and enterprise AI adoption as these market leaders provide a snapshot of early 2026 performance.
A diverse group of market leaders across fintech, AI, and healthcare are set to report fourth-quarter results, providing a critical pulse check on enterprise spending and consumer resilience. Investors are particularly focused on Intuit’s AI integration and SoundHound’s scaling revenue as benchmarks for the broader tech sector.
A broad spectrum of mid-to-large cap companies across construction, fintech, and e-commerce are set to report fourth-quarter results, providing a critical pulse check on the 2026 economic outlook. Investors are focused on how these firms navigated late-2025 interest rate volatility and shifting consumer demand.
A diverse group of sector leaders, including cybersecurity firm Zscaler and infrastructure giant MasTec, are set to report quarterly results on February 26, 2026. Investors are closely watching for signs of resilient enterprise spending and the impact of sustained high interest rates on capital-intensive industries.
Source: markets.financialcontent.com · markets.financialcontent.com
HP Inc. reported a Q1 earnings beat but issued a cautious outlook for fiscal 2026, citing a persistent memory chip shortage and a double-digit decline in PC shipments. Despite strong AI PC adoption and Windows 11 upgrades, the company expects profits to hit the lower end of its guidance due to supply chain volatility and tariff pressures.
Woolworths Group has reported a significant decline in first-half profits after a court ruling mandated approximately $710 million in back pay, interest, and taxes. The financial hit stems from long-standing underpayment issues, highlighting the severe regulatory and legal risks facing Australia's largest retailers.
Globus Medical (GMED) and Everus Construction Group (ECG) both reported an advance in fourth-quarter profits, signaling operational strength in the MedTech and infrastructure sectors. These results highlight successful post-merger synergies for Globus and a strong independent performance for the recently spun-off Everus.
Allison Transmission reported a significant Q4 earnings miss, posting $1.18 per share against a $1.55 estimate, while Alcon narrowly missed expectations with a core EPS of $0.78. These results highlight a divergence in sectoral resilience, with heavy-duty industrials facing sharper headwinds than the healthcare and vision care markets.
EDP Renováveis (EDRVF) is scheduled to release its quarterly earnings this Wednesday, providing a critical update on its €20 billion strategic plan. Investors are closely monitoring the company's asset rotation strategy and its ability to navigate a high-interest-rate environment while expanding its global wind and solar footprint.
Standard BioTools and Evolent Health released their Q4 and full-year 2025 financial results, marking a critical inflection point for both the life sciences tools and value-based care sectors. The reports highlight a focus on operational efficiency and the integration of large-scale acquisitions as both companies navigate a complex macroeconomic environment.
Acadia Healthcare and HNI Corporation are set to report Q4 2025 results, offering critical insights into behavioral health demand and corporate office furniture spending. Investors are closely watching Acadia's labor cost management and HNI's integration of Kimball International amid shifting workplace trends.
Home Depot reported fourth-quarter results that exceeded analyst expectations for earnings and revenue, yet the retailer warned of a 'frozen' housing environment as customer transactions fell 8.5%. Despite the muted performance, the company raised its quarterly dividend by 1.3% to $2.33 per share, signaling caution in a volatile macro climate.
A trio of mid-cap leaders across the industrial, medical technology, and environmental sectors reported strong quarterly results today, exceeding both top and bottom-line analyst estimates. Ferguson Enterprises, Orthofix Medical, and Enviri Corp all introduced positive fiscal year 2026 outlooks, signaling a robust start to the year for diversified market segments.
Root and Catalyst Pharmaceuticals are scheduled to report quarterly results on Wednesday, offering investors a dual look at high-growth technology and healthcare resilience. Both companies face critical tests regarding their respective expansion strategies and bottom-line improvements in a shifting macroeconomic environment.
Edenred reported a rise in full-year 2025 net profit, underscoring the resilience of its digital-first platform and the successful expansion of its mobility and fleet management services. The company continues to benefit from high digital penetration and sustained financial income from its float.
Source: rttnews.com · finanznachrichten.de
Ovintiv and Grupo Aeroportuario del Pacifico (PAC) have released fourth-quarter results alongside ambitious 2026 guidance, highlighting a strategic pivot toward long-term capital efficiency. These reports underscore a growing trend of multi-year forecasting as companies seek to reassure investors amid shifting macroeconomic and regulatory landscapes.
Source: Seeking Alpha · Seeking Alpha
Douglas Dynamics and Novanta both reported stronger-than-expected earnings and revenue for the final quarter of 2025, signaling resilience in industrial and technology sectors. Both companies introduced optimistic fiscal year 2026 guidance, reflecting confidence in municipal spending and medical technology demand.
Source: Seeking Alpha · Seeking Alpha
Ziff Davis and Tennant Company both reported disappointing quarterly results, missing analyst expectations on both revenue and earnings. While Tennant provided a roadmap for the coming year, Ziff Davis took the more cautious step of postponing its full-year 2026 guidance, signaling deep uncertainty in the digital media landscape.
Woodside Energy achieved record annual production of 188.8 million barrels of oil equivalent, driven by the successful ramp-up of the Sangomar project and high reliability across its LNG portfolio. However, a significant decline in realized commodity prices has pressured financial margins, highlighting the transition from a period of energy price volatility to a more stabilized market environment.
Kratos and BWXT reported strong Q4 2025 results, characterized by record-breaking backlogs and significant organic growth in specialized defense and commercial sectors. While BWXT is capitalizing on a massive surge in commercial nuclear demand, Kratos is seeing momentum in unmanned systems and space communications, signaling a robust outlook for high-tech defense contractors in 2026.
A diverse slate of earnings from retail giants like Lowe's and Macy's to industrial and utility leaders will provide a critical pulse check on the U.S. consumer and infrastructure spending. Investors are particularly focused on margin preservation amidst fluctuating interest rate expectations and shifting discretionary spending patterns.
Source: Seeking Alpha · Seeking Alpha
Axon Enterprise is set to report Q4 2025 results, with investors focused on the adoption of AI-driven tools like Draft One and the continued rollout of TASER 10. Meanwhile, specialty pharma players Corcept and Supernus prepare to disclose their own year-end performance amid shifting regulatory and competitive landscapes.
Tarsus Pharmaceuticals and ORIC Pharmaceuticals reported fourth-quarter 2025 results, highlighting a pivotal shift toward commercial scaling and clinical data maturation. While Tarsus focuses on the rapid adoption of XDEMVY, ORIC is advancing its oncology pipeline with key data readouts expected in 2026.
Paymentus and Primoris both reported robust fourth-quarter 2025 financial results that exceeded expectations, yet both stocks faced immediate selling pressure. This divergence highlights a market increasingly focused on 2026 guidance and profit-taking following strong year-to-date runs.
Source: markets.financialcontent.com · markets.financialcontent.com
Iovance Biotherapeutics and Fidelity National Financial are preparing to report Q4 2025 results, with investors focusing on the commercial scaling of cell therapies and the resilience of the title insurance market. These reports will provide critical data on biotech commercialization and the health of the U.S. housing sector.
Keurig Dr Pepper is set to report its fourth-quarter 2025 results, with investors focused on whether Dr Pepper's market share gains can offset continued volatility in the Keurig coffee segment. The report will be critical in determining if the company's recent 'dirty soda' innovations and marketing shifts are effectively capturing younger demographics.
Bank of America has raised its price target for The Coca-Cola Company to $88, maintaining a Buy rating following positive management commentary. Analyst Peter Galbo highlighted the company's robust execution and 'bottler-friendly' performance as key drivers for continued growth.
Source: Insider Trading · Yahoo! News
Nvidia’s upcoming quarterly results serve as a critical pivot point for a US stock market grappling with the dual pressures of AI-driven sector disruption and legal uncertainty following a Supreme Court ruling on trade tariffs. As the world’s largest company, Nvidia must satisfy sky-high expectations to stabilize a volatile tech sector that has seen software and service industries falter.
Source: Reuters (za) · Reuters (my)
Wall Street is bracing for a pivotal week as Nvidia's fiscal fourth-quarter results and reports from major software firms provide a litmus test for the AI trade. Amidst a shaky start to 2026 for megacap tech and broader market uncertainty following a Supreme Court ruling on tariffs, these earnings will determine if the AI-driven bull market can sustain its momentum.
Source: List.metadata.agency (in) · Reuters (pk)
As the Q4 2025 earnings season intensifies, investors are closely monitoring Diamondback Energy, Apple Hospitality, and BWX Technologies for insights into Permian production, travel demand, and nuclear energy growth. These previews highlight a diverse market landscape where operational efficiency and sector-specific tailwinds are driving performance expectations.
AdvanSix and Metallus reported Q4 2025 results that underscore a diverging landscape for mid-cap industrials, with chemical recovery and defense-driven steel demand serving as primary catalysts. While AdvanSix grapples with fertilizer pricing volatility, Metallus continues to capitalize on structural tailwinds in the energy and defense sectors.
Source: insidermonkey.com · insidermonkey.com
Barings BDC (BBDC) reported its fourth-quarter 2025 financial results, underscoring the resilience of its senior secured portfolio in a complex interest rate environment. The earnings call highlighted the company's focus on middle-market credit quality and its strategic positioning for the 2026 fiscal year.
Source: insidermonkey.com · finance.yahoo.com
DXP Enterprises (NASDAQ: DXPE) has scheduled its fourth-quarter and full-year 2025 financial results release, providing a critical window into the health of the industrial distribution sector. As a key provider of MRO and OEM solutions, the company's performance will serve as a bellwether for broader industrial demand and supply chain stabilization.
Source: Rutland Herald · wallstreet-online.de
A trio of high-growth companies across genomics, biotechnology, and digital logistics are set to report quarterly results this Monday. Investors will be closely monitoring GeneDx's path to profitability, PepGen's clinical cash runway, and Freightos's transaction volume growth.
A flurry of Q4 2025 earnings reports reveals a bifurcated market where specialized medical technology and energy infrastructure are outperforming, while consumer discretionary and managed services face margin pressures. Glaukos Corporation and Targa Resources emerged as standout performers, signaling robust demand in high-barrier-to-entry sectors.
According to our own tracking database, this category has accumulated 463 earnings stories since coverage began. This page aggregates the latest earnings stories within our finance coverage area. Every story is cross-referenced across multiple primary sources, scored for sentiment and operational impact, and timestamped so fresh developments surface first. We track quarterly results, guidance, estimates and surface the angles a domain expert would actually read.
Story selection follows our editorial methodology — impact scoring weights regulatory, financial, and operational developments distinctly. Sentiment is classified across five tiers via supervised classification trained on labeled industry corpora. See our glossary for term definitions and our trends index for longitudinal patterns across the finance beat.
Stories only surface on this page once the classifier scores them at a minimum 35 percent relevance to the category. According to that methodology, reviewed July 2026, this follows multi-source corroboration standards recommended by journalism research bodies such as the Reuters Institute for the Study of Journalism.
See something wrong on this page — a wrong stat, a broken source link, a miscategorized story? Report a data issue.
| Signal | What it tells you |
|---|---|
| Verified by N sources | Confidence the story isn't a single-source rumor — N≥2 means the development is independently corroborated. |
| Impact score (1-10) | Estimated regulatory, financial, or operational impact. 8+ indicates a story experienced operators should act on. |
| Sentiment | Five-tier classification (very bullish through very bearish) trained on labeled finance-specific corpora. |
| Time stamp | Recency. Fresh stories (under 1h) render with a highlighted timestamp; stale stories (≥24h) render dimmed. |